skip to Main Content
Submit your abstract Register here
Add to Calendar 2021-06-23 2021-06-26 America/Los_Angeles International Liver Congress 2021 Digital

Second call for regular or high-profile late-breaker abstracts - 10-27 April

EASL is pleased to announce the second round of abstract submissions for ILC 2021. We are calling for scientists, researchers, investigators, and companies to submit regular and high-profile, late-breaker abstracts, 10–27 April 2021.

ILC 2021 list of accepted abstracts from the first round

Discover all the accepted abstracts for ILC 2021 from the first round of submission. We are now working on defining all the sessions for the abstracts presentations and we are planning to have them in place by 18 May.

See the list of accepted abstracts

Best reasons to submit your abstract to ILC 2021

Network with experts

Present your abstract and interact with 10,000+ members of the international liver community at the event

Boost your career

  • If your abstract is selected, it will be published in the ILC 2021 Abstract Book, a supplement of the Journal of Hepatology (IF 20.582, top-rated journal on liver disease).
  • Over 8,000 downloads of the ILC 2020 Abstract Book
  • Inclusion in the scientific programme of the event

Gain recognition

Stand to win an EASL Award and receive it in the presence of numerous ILC 2021 delegates.

Contribute to beating liver disease

We're shaping the future of hepatology. Together.

ILC 2021 abstract deadlines

  • First round, abstract submission deadline: 02 February 2021 (23.59 CET)
  • First round, abstract notification: 02 April 2021
  • Poster submission deadline: 7 June 2021
  • Second round, regular and high-profile, late-breaker abstracts submission period: 10– 27 April 2021
  • Second round, late-breaker notification: 18 May 2021

Important information
Those abstract presenters who took part in the first round and who were selected are eligible to register with early fees. They will receive a personal code for the early-fee discount, together with the abstract notification. Their final early-fees deadline is: 12 April 2021, 23:59 CET.

Those abstract presenters who took part in the second round will have ten days after receiving their notification on 18 May to register with early fees. They will receive a personal code for the early-fee discount, together with the abstract notification. Their final early-fees deadline is: 28 May 23:59 CET.

Waivers for submitters from 29 countries defined as low-income economies
Abstract submitters from low-income economies* will be exempted from the EUR 50 required to submit their abstract(s). If you are from one of these countries, you can submit your abstract cost-free.

*As per the World Bank classification:
Low-income economies refers to this listing of these 29 countries: Afghanistan, Burkina Faso, Burundi, Central African Republic, Chad, Congo Dem. Rep, Eritrea, Ethiopia, Gambia The, Guinea, Guinea-Bissau, Haiti, Korea Dem., People's Rep., Liberia, Madagascar, Malawi, Mali, Mozambique, Niger, Rwanda, Sierra Leone, Somalia, South Sudan, Sudan, Syrian Arab Republic, Tajikistan, Togo, Uganda, Yemen Rep.

ILC 2021 full list of abstract categories

Click and discover all the categories.

  • Acute liver failure and drug induced liver injury
  • Alcoholic liver disease
  • Cirrhosis and its complications (1): Portal Hypertension
  • Cirrhosis and its complications (2): ACLF and Critical illness
  • Cirrhosis and its complications (3): Other clinical complications except ACLF and critical illness
  • Cirrhosis and its complications (4): Experimental and pathophysiology
  • Fibrosis
  • Gut microbiota and liver disease
  • Imaging and drug targeting
  • Immune-mediated and cholestatic disease: Clinical aspects
  • Immune-mediated and cholestatic: Experimental and pathophysiology
  • Immunology
  • Liver development, physiology and regeneration
  • Liver transplantation and hepatobiliary surgery: Clinical aspects
  • Liver transplantation and hepatobiliary surgery: Experimental
  • Liver tumours: Clinical aspects except therapy
  • Liver tumours: Experimental and pathophysiology
  • Liver tumours: Therapy
  • Molecular and cellular biology
  • NAFLD: Clinical aspects except therapy
  • NAFLD: Diagnostics and non-invasive assessment
  • NAFLD: Experimental and pathophysiology
  • NAFLD: Therapy
  • Non-invasive assessment of liver disease except NAFLD
  • Nurses and Allied Health Professionals research in hepatology
  • Public Health
  • Rare liver diseases (including paediatric and genetic)
  • Viral Hepatitis A, B, C, D, E: Virology
  • Viral hepatitis A/E: Clinical aspects
  • Viral hepatitis B/D: Clinical aspects except therapy
  • Viral hepatitis B/D: Therapy
  • Viral hepatitis C: Clinical aspects except therapy
  • Viral Hepatitis C: Post SVR and long term follow up
  • Viral hepatitis C: Therapy and resistance

Abstract submission information

Types of presentations

All accepted abstracts, submitted as regular abstracts or late-breakers, will then be presented either as:

  • an oral presentation or
  • a poster presentation

The best posters will be selected for ePoster sessions and the authors will be notified at the end of May 2021.

Instructions on how to prepare your oral or poster presentation will be provided shortly.

Download the ILC 2021 Publishing Authorisation

Oral and poster presentation templates

Once your research has been accepted, you can use the following oral and poster presentation templates. You are allowed to use your own templates, as long as they follow the requested oral presentation and poster presentation formats.

Back To Top